Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - inflammatory+disease
5
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Interleukin 24 (IL-24) to treat
inflammatory disease
s
Abstract: Proinflammatory T-helper 17 cells (Th17) play important roles in host immune defense against infection, but uncontrolled activation of these cells, known as the Th17 response, may cause autoimmune and auto
inflammatory disease
s (uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease) through the effects of Th17 lineage...
Published: 4/8/2024
|
Inventor(s):
Rachel Caspi
,
Mary Mattapallil
,
Reiko Yamane
,
Wai Po Chong
Keywords(s):
Caspi
,
Crohn’s disease
,
IL-24
,
inflammatory disease
,
interleukin 24
,
Multiple sclerosis
,
National Eye Institute
,
NEI
,
proinflammatory T-helper 17 cell
,
RHEUMATOID ARTHRITIS
,
Th17
,
uveitis
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
Application > Therapeutics
,
TherapeuticArea > Immunology
Use of Interleukin (IL)-34 to Treat Retinal Inflammation and Neurodegeneration
Abstract: Interleukin (IL)-34 is a homodimer that is produced mainly by keratinocytes, neuronal cells and regulatory T cells (Tregs). It is believed to play important roles in chronic inflammation and the homeostasis of microglia. Currently, there is no effective treatment for many types of retinal degeneration. An improved treatment of autoimmune uveitis...
Published: 4/8/2024
|
Inventor(s):
Rachel Caspi
,
Mary Mattapallil
,
Zhijian Wu
Keywords(s):
AAV Vector
,
Caspi
,
GENE THERAPY
,
IL-34
,
inflammatory disease
,
Inherited Retinal Dystrophies
,
Interleukin 34
,
National Eye Institute
,
NEI
,
NEURODEGENERATION
,
Photoreceptor Death
,
Retinal degeneration
,
Retinal Inflammation
,
uveitis
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
Application > Therapeutics
,
TherapeuticArea > Opthamology
,
TherapeuticArea > Eye / Ear / Nose / Throat
,
TherapeuticArea > Immunology
Muramyl Dipeptide as a Therapeutic Agent for Inflammation
The nucleotide-binding oligomerization domain 2 (NOD2) protein plays a key role in innate immunity as a sensor of muramyl dipeptide (MDP), a breakdown product of bacterial peptidoglycan. Bacterial peptidoglycan promotes the innate immune response through the activation of Toll-like receptor 2 (TLR2), which ultimately provokes inflammation. Activation...
Published: 10/28/2024
|
Inventor(s):
Warren Strober
Keywords(s):
Autoimmune
,
AUTOIMMUNE DISEASE
,
Autoimmune disorder
,
Autoimmunity
,
BBXXXX
,
BCXXXX
,
BOWEL
,
Crohn disease; Inflammatory bowel disease 1
,
Crohn's disease
,
Dipeptide
,
IB3XXX
,
IBD
,
IBXXXX
,
IL-12
,
Inflammation
,
INFLAMMATORY
,
inflammatory bowel disease
,
Inflammatory bowel disease 1
,
inflammatory disease
,
INTERLEUKIN
,
INTERLEUKIN-12
,
IRF4
,
IXXXXX
,
MDP
,
Muramyl
,
NOD2
,
peptidoglycan
,
TLR
,
TLR2
,
Toll-like
,
Toll-like receptors
,
Ulcerative Colitis
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
Application > Therapeutics
,
TherapeuticArea > Immunology
,
Application > Research Materials
,
Application > Diagnostics
Antibodies Against TL1A, a TNF-Family Cytokine, for the Treatment and Diagnosis of Autoimmune
Inflammatory Disease
s
Autoimmune
inflammatory disease
s occur in greater than five percent of the United States population; this disease group includes asthma, multiple sclerosis, rheumatoid arthritis, and lupus. Treatments generally include immunosuppressants or anti-inflammatory drugs, which can have serious side effects; recently, more specific immunomodulatory therapies...
Published: 7/30/2024
|
Inventor(s):
Francoise Meylan
,
Yun-Jeong Song
,
Richard Siegel
Keywords(s):
antibodies
,
ANTIBODY
,
ANTI-HUMAN
,
Anti-mouse
,
Autoimmune
,
diagnostic
,
DR3
,
IA3XXX
,
IAXXXX
,
IB3XXX
,
IBXXXX
,
Immunomodulation
,
immuno-modulator
,
immunomodulatory
,
INFLAMMATORY
,
inflammatory disease
,
IXXXXX
,
monoclonal
,
Monoclonal Antibodies
,
Monoclonal Antibody
,
Patent Category - Biotechnology
,
therapeutic
,
TL1A
,
tnf
,
TNFRSF25
,
TNFSF15
,
tumor necrosis factor
,
USES
Category(s):
Collaboration Sought > Collaboration
,
Application > Research Materials
,
Application > Therapeutics
,
Application > Diagnostics
,
TherapeuticArea > Immunology
Peptide mimics of melanocyte stimulating hormone
The human gut naturally contains a large mass of microorganisms that collectively perform critical functions, such as degradation of otherwise indigestible components of our diet. The mechanisms that suppress host inflammatory responses to these living cultures within our GI tract are not well understood – the presence of minute amounts of the...
Published: 3/23/2021
|
Inventor(s):
Jesse Roth
Keywords(s):
Inflammatory disease
Category(s):
Inflammation and Autoimmunity